IA
CGTX icon

IFP Advisors’s Cognition Therapeutics CGTX Stock Holding History

IFP Advisors’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000
Closed -$1.35K – 4905
2025
Q3 		$1.35K Buy
+1,000
New +$1.36K ﹤0.01% 3833
2023
Q1 		– Sell
-750
Closed -$10K – 3538
2022
Q4 		$10K Hold
750
– – ﹤0.01% 3365
2022
Q3 		$10K Hold
750
– – ﹤0.01% 3624
2022
Q2 		$10K Hold
750
– – ﹤0.01% 3381
2022
Q1 		$10K Buy
+750
New +$2.89K ﹤0.01% 3381

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

IFP Advisors's CGTX Position: Q4 2025 in Review

IFP Advisors sold out of Cognition Therapeutics (CGTX) in Q4 2025, closing a stake of 1,000 shares — an estimated $1.35K sold.

IFP Advisors first reported a position in CGTX in Q1 2022 and held it in 5 quarters. The position peaked at $10K in Q4 2022. 78 funds tracked by Wall St. Rank hold CGTX as of Q4 2025.

  • IFP Advisors reported no remaining Cognition Therapeutics position as of Q4 2025 after selling out during the quarter.
  • IFP Advisors sold 1,000 Cognition Therapeutics shares in Q4 2025, an estimated $1.35K.
  • IFP Advisors first reported a position in Cognition Therapeutics in Q1 2022 and held it in 5 quarters.
  • IFP Advisors's Cognition Therapeutics position peaked at $10K in Q4 2022.
  • 78 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q4 2025.

Based on IFP Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.